Total Payments
$10,913
2024 Payments
$2,634
Companies
18
Transactions
548
Medicare Patients
3,179
Medicare Billing
$461,485
Payment Breakdown by Category
Food & Beverage$10,854 (99.5%)
Education$59.05 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,854 | 545 | 99.5% |
| Education | $59.05 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $2,078 | 75 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,464 | 67 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,358 | 55 | $0 (2024) |
| ITI, Inc. | $1,252 | 69 | $0 (2023) |
| ABBVIE INC. | $1,118 | 68 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $611.31 | 73 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $557.16 | 21 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $510.70 | 30 | $0 (2024) |
| Lundbeck LLC | $433.65 | 31 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $386.77 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,634 | 112 | Alkermes, Inc. ($446.05) |
| 2023 | $3,480 | 140 | Teva Pharmaceuticals USA, Inc. ($899.71) |
| 2022 | $2,322 | 140 | Alkermes, Inc. ($624.63) |
| 2021 | $2,477 | 156 | ITI, Inc. ($439.84) |
All Payment Transactions
548 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: CNS | ||||||
| 11/14/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: CNS | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Central Nervous System | ||||||
| 11/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: CNS | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.56 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 836 | 2,137 | $318,490 | $128,381 |
| 2022 | 6 | 896 | 2,049 | $281,791 | $120,779 |
| 2021 | 6 | 871 | 2,137 | $210,514 | $125,042 |
| 2020 | 3 | 576 | 1,463 | $182,039 | $87,282 |
Total Patients
3,179
Total Services
7,786
Medicare Billing
$461,485
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 415 | 1,385 | $164,899 | $77,851 | 47.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 385 | $71,225 | $16,601 | 23.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 161 | 174 | $35,617 | $15,980 | 44.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 145 | 153 | $26,749 | $12,879 | 48.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 40 | 40 | $20,000 | $5,070 | 25.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 421 | 1,362 | $143,430 | $69,421 | 48.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 229 | 256 | $51,157 | $24,830 | 48.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 157 | 169 | $25,849 | $12,438 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 175 | $32,375 | $7,426 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 66 | $18,480 | $4,173 | 22.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 21 | 21 | $10,500 | $2,491 | 23.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 452 | 1,620 | $127,381 | $81,704 | 64.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 228 | 259 | $38,679 | $25,271 | 65.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 136 | 150 | $17,000 | $11,074 | 65.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 71 | $13,135 | $3,396 | 25.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 18 | 18 | $9,000 | $2,267 | 25.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 19 | $5,320 | $1,329 | 25.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 347 | 1,206 | $132,792 | $63,808 | 48.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 139 | 157 | $33,208 | $15,798 | 47.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 90 | 100 | $16,039 | $7,676 | 47.9% |
About Michael Solano
Michael Solano is a Licensed Psychiatric Technician healthcare provider based in Upland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609094945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Solano has received a total of $10,913 in payments from pharmaceutical and medical device companies, with $2,634 received in 2024. These payments were reported across 548 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($10,854).
As a Medicare-enrolled provider, Solano has provided services to 3,179 Medicare beneficiaries, totaling 7,786 services with total Medicare billing of $461,485. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Licensed Psychiatric Technician
- Other Specialties Psychiatric/Mental Health
- Location Upland, CA
- Active Since 04/23/2007
- Last Updated 08/30/2019
- Taxonomy Code 167G00000X
- Entity Type Individual
- NPI Number 1609094945
Products in Payments
- CAPLYTA (Drug) $1,568
- ARISTADA (Drug) $1,435
- VRAYLAR (Drug) $1,118
- REXULTI (Drug) $947.40
- AUSTEDO (Drug) $736.51
- ABILIFY MAINTENA (Drug) $723.46
- LYBALVI (Drug) $643.25
- LATUDA (Drug) $611.31
- INVEGA SUSTENNA (Drug) $557.16
- UZEDY (Drug) $390.06
- QELBREE (Drug) $342.97
- Austedo XR (Drug) $310.75
- FANAPT (Drug) $249.56
- Auvelity (Drug) $211.40
- Qelbree (Drug) $167.73
- INGREZZA (Drug) $147.40
- TRINTELLIX (Drug) $137.75
- HETLIOZ (Drug) $137.21
- NUPLAZID (Drug) $114.98
- NUEDEXTA (Drug) $101.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Licensed Psychiatric Technician Doctors in Upland
Cesar Escamilla, Lpt, LPT
Licensed Psychiatric Technician
Licensed Psychiatric Technician
Ruth Jurado
Licensed Psychiatric Technician
Licensed Psychiatric Technician
Andrea Hernandez
Licensed Psychiatric Technician
Licensed Psychiatric Technician
Robert Orona
Licensed Psychiatric Technician
Licensed Psychiatric Technician